Alerte de la F.D.A (extrait en Anglais)

The FDA also issued a safety alert in November 2018, warning of a risk of worsening disability within weeks or months of stopping Gilenya’s use. While this risk is rare, the agency noted that it can be severe and result in permanent disability.